Sign in
Taking peopleNo phase

Proton beam or X-ray radiation for adults with brain tumors

Compares proton and X-ray radiation for adults with brain tumors.

Key facts

Who runs it
Tata Memorial Centre
Where
India1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors
Status
Recruiting
People taking part
156 people, planned
Started
1 Jul 2025
Expected to end
31 Dec 2032
Type of study
Interventional, 2 groups
Treatments tested
  • Proton Beam Therapy
  • Photon Radiotherapy
Record updated
16 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a primary brain tumor expected to allow survival of more than 5 years, who are planned for radiotherapy to one area of the head. They get proton or photon (X-ray) radiotherapy by chance.

Age
18 to 70 years at the time of radiotherapy.
Sex
All sexes can join.
Disease stage
Primary brain tumor, diagnosed by tissue test or scans, with an expected survival of more than 5 years. Examples: grade 2-3 diffuse glioma, low-grade glial or glioneuronal tumors, ependymoma, meningioma, pituitary tumors, schwannoma, craniopharyngioma. Karnofsky Performance Status (a score of daily functioning) of 60 or more.
Earlier treatment
People who have had radiotherapy to the same area before cannot join.

Main reasons for not taking part

  • Repeat radiotherapy (re-irradiation)
  • Radiotherapy given only to ease symptoms (palliative)
  • Tumor in several places in the brain (multifocal or multicentric)
  • Planned radiotherapy to the whole brain or the brain and spine
  • Planned hypo-fractionated or stereotactic radiotherapy (few large doses)

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Primary brain tumors
  • Age at irradiation: 18 to 70 years
  • Karnofsky Performance Status ≥ 60
  • Diagnosis (histopathological/ radiological) of primary brain tumor with an expected survival of >5 years (e.g., grade 2-3 diffuse glioma, low-grade glial/ glioneuronal tumors, ependymoma, meningioma, pituitary tumors, schwannoma, craniopharyngioma, etc.)
  • Planned for focal cranial radiotherapy
  • Informed consent taken

Who cannot take part

  • Re-irradiation
  • Palliative radiotherapy
  • Planned for whole brain irradiation or craniospinal irradiation
  • Planned for hypo-fractionated or stereotactic radiotherapy
  • Multifocal or multicentric disease

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will be done in adults with brain tumors having good prognosis requiring treatment with radiotherapy. The current practice for brain radiotherapy involves treatment using X rays (photon radiotherapy). Proton beam therapy is a more advanced form of delivering radiation, which allows the reduction of the dose of radiation to the parts of the brain surrounding the tumor. After treatment with photon radiotherapy, certain late effects of radiation, like memory decline, hormonal deficits, hearing loss, and worsening of neurological function, can occur in some patients. From the evaluation of dose profiling, proton beam therapy has the potential to reduce the possibility of side effects by reducing the dose to critical organs. However, there is no clinical data to demonstrate whether the theoretical dose reduction translates to a clinically meaningful benefit. In the proposed study, 156 patients will be randomly allocated to either proton or photon radiotherapy in 1: 1 ratio. The primary objective of the study is to explore whether proton therapy improves functional survival, which is life expectancy without recurrence, death, or complications from radiotherapy.

The 2 groups in the trial

  • Photon therapy (standard arm)Other group

    Patients in the standard arm will undergo focal cranial radiotherapy using photons (X-rays) with image guidance using IMRT, VMAT, or helical intensity-modulated techniques.

    Treatment: Photon Radiotherapy

  • Proton beam therapy (experimental arm)Treatment being tested

    The patients in the experimental arm will undergo focal radiotherapy to an equivalent dose using proton beam therapy.

    Treatment: Proton Beam Therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Proton Versus Photon Radiotherapy In Adults With Primary Brain Tumors Evaluating Functional Survival: A Phase 3 Randomized Controlled Trial (PRIDE)
Plain-language title
Proton beam or X-ray radiation for adults with brain tumorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06831461, who can take part
Publications
Record updated
16 September 2025